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Abstract
The vaginal microbiome is associated with women’s health, including but not limited to the
pathogenesis of bacterial vaginosis, adverse pregnancy outcomes including preterm birth and
sexually transmitted infections. However, there has been very limited research on the urinary
microbiome and its relationship to the vaginal microbiome. We sought to predict the vaginal
microbiome profile using clean catch urine samples from the same person. Here, paired vaginal
and urine samples were collected and sequenced by 16S ribosomal RNA sequencing. Alpha and
beta diversity analysis showed that there was no significant difference between the paired vaginal
and urine microbiomes. In fact, a vaginal microbiome is generally more similar to its paired urine
microbiome than it is to vaginal microbiomes from other people or to the paired buccal and rectal
microbiome from that individual. Additionally, the abundance of most of the taxa in the vaginal
microbiome was linearly related to that in the paired urine microbiome. These data suggested that
the urine microbiome could be used to predict the vaginal microbiome of the same person.
However, the urine microbiome contains a significantly larger number of taxa than the paired
vaginal microbiome, which may be from the urinary infections or contamination. After removing
these additional taxa from the feature table of the microbiomes, the vaginal microbiome exhibited
a more similar profile to the paired urine microbiome in the analysis of diversities, linear regression
of taxa abundance, and the community type of the microbiomes. In total, our data suggest that the
vaginal microbiome is similar to and could be predicted by the paired urine microbiome.
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Introduction
The human vaginal microbiome has demonstrated a complex, mutually beneficial
relationship with the host. Early research was dependent on culture-based methods which proved
inadequate due to the fact that most of the species commonly found in the vaginal microbiome are
intractable to common culture techniques (Huang et al., 2014; Brown et al., 2007). 16S rRNA
Taxonomic Profiling using high throughput next generation sequencing has opened a path to this
relatively new field of study and provided a much more complete picture of the species comprising
the vaginal microbiome. With this technique, our understanding of the vaginal microbiome has
greatly improved, and light has been shed on its role in women’s health, health disparities and
pregnancy.
The vaginal microbiome has been shown to change and experience a shift in taxonomical
abundances and diversity throughout pregnancy, with the greatest change in the first two trimesters
(DiGiulio et al., 2015; MacIntyre et al., 2015; Serrano et al., 2019). Several studies (Fettweis et
al., 2019; Hočevar et al., 2019; Tabatabaei et al., 2019) have recently identified a correlation
between the composition of the vaginal microbiome during early gestation and preterm birth,
which comprises approximately10% of all births in the United States and worldwide (Martin et
al., 2019). Preterm birth, which is defined as live birth before 37 weeks of gestation, is the second
most common cause of neonatal death in the world and is among the most common causes of
infant mortality in middle-to-high-income economies (Liu et al., 2016). Approximately 15 million
preterm births occur globally every year (Blencowe et al., 2012). The total cost of preterm birth
alone in the United States is estimated to be $26.2 billion annually (Behrman, R. E. & Butler, A.
S., 2007), and this represents costs only up to and associated with birth. Long term effects,
associated with neurological development, long term care, and the significant less tangible
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psychological effects on the developing individual, are also devastating for the whole family.
Recently, our group identified that the abundance of multiple bacterial taxa are associated with
risk of preterm birth, four of which; BVAB1, Sneathia amnii, TM7-H1, and a cluster of Prevotella
species, were used to develop a predictive model for predicting risk of preterm with high sensitivity
and specificity (Fettweis et al., 2019). Interestingly, this predictive model using the four taxa was
most relevant using data from the early stages of pregnancy and may be most useful to predict
increased risk for preterm birth in higher-risk populations. These and other studies have identified
additional taxa that are associated with increased risk of preterm birth, including but not limited to
Atopobium vaginae, Megasphere cluster52, Mobiluncus curtsii, Molbiluncus mulieris,
Porphyromonas uenonis_asaccharolytica, Sneathia sanguinegens, Gardnerella vaginalis,
Dialister cluster51, Prevotella bivia, Mageeibacillus indolicus, Prevotella buccalis, and Dialister
micraerophilus along with unidentified species belonging to the genera Peptoniphilus and
Streptococcus (Hyman et al., 2014; Callahan et al., 2017; Brown et al., 2019; Elotvitz et al., 2019).
One such study found that depletion of Lactobacillus spp. coupled with an increased abundance
of Sneathia spp. were associated with subsequent funisitis (inflammation of the connective tissue
of the umbilical cord) which has been shown to be associated with a lower gestational age at
delivery and FIRS (the fetal inflammatory response syndrome), which is a subclinical condition
that has been described in fetuses who present with preterm labor and premature rupture of fetal
membranes (Brown et al., 2018). It is important to note that several of these taxa were only found
to have a statistical correlation with preterm birth in certain cohorts but not others (i.e. high risk
vs low risk). The ability to predict preterm birth may allow for steps towards prevention and early
intervention. More research is required to further elucidate this relationship in the hopes of
predicting preterm birth before it happens.
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Our understanding of the vaginal microbiota and its relationship with the host continues to
evolve. In addition to preterm birth, the microbiome of the female reproductive tract is correlated
with pelvic inflammatory disease (Sharma et al., 2014), UTIs (Kirjavainen et al., 2009), HIV
susceptibility (Saxena et al., 2012), STI susceptibility (Lee et al., 2013; Torcia M.G. 2019), and
Bacterial Vaginosis (BV) (Onderdonk et al., 2016). It was believed early on that most vaginal
microbiomes considered to be “healthy” with a pH under 4.5 and a lower species diversity
distribution were predominantly colonized by Lactobacillus-dominant microbiota (Hyman et al.,
2005). BV, which is the most common cause of vaginal discharge seen in women within the
reproductive age range (Oakley et al., 2008), is described by the CDC as an imbalance of “good”
and “harmful” bacteria in the vagina that often presents symptoms such as thin, gray, white or
green vaginal discharge, a foul-smelling "fishy" vaginal odor, itching, and burning during urination
and is associated with babies born prematurely and/or underweight. This research showed that
vaginal microbiomes of patients who diagnosed with BV were comprised of a more diverse array
of anaerobic bacteria and lacked the Lactobacillus-dominance seen in patients who were
considered healthy (Ma et al., 2012; Fredricks, Fiedler, & Marrazzo, J. M., 2005). More recent
studies have shown that these differences may be attributed to differences in racial background
and/or socioeconomic factors (Zhou et al., 2007; Ravel et al., 2011; Fettweis et al., 2014;
Borgdorff et al., 2017). Vaginal microbiomes dominated by more than one species of
Lactobacillus, while common in Caucasian women, were found to be less prevalent in African
American women, which is believed to play a role in the fact that women of African descent are
~50% more likely to experience preterm birth than those of European ancestry (Martin et al.,
2019). The continually evolving understanding of the relationship between the vaginal microbiome
and health disparity makes studies of the vaginal microbiome even more important.
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The current method for harvesting the genetic material used for 16S rRNA Taxonomic
Profiling is usually from vaginal swabs. While this strategy has proven reliable and the gold
standard for vaginal microbiome analysis, there has been very limited study on alternate techniques
and approaches for acquiring template DNA or RNA. Although other options like flocked swabs,
the Evalyn® self-sampling device, sterile plastic spatulas, and cervical brushes have shown to
produce comparable results (Mitra et al., 2017), their collection techniques are identical in
principle to vaginal swabs. The lack of alternatives presents several issues. Firstly, vaginal swabs
are not considered to be a standard in physician-ordered labs. This presents difficulty in acquiring
vaginal microbiome samples when studying a cohort that is not subject to regular vaginal swab
collection as work is often done on retrospective samples. Secondly, it is an invasive technique
that begs the need for a more accepted collection method that is easier for the study participant to
provide. Utilizing urine as an alternative to vaginal swabs would provide a source that is collected
more routinely as part of physician-ordered labs, is non-invasive, is well-accepted by women, and
is often taken as a normal part of clinical procedures. Additionally, samples can be collected and
stored at 4C on filter paper (Kunin & Buesching 2000), which would be beneficial in areas
without access to freezers, such as underdeveloped regions in Africa with populations that are
higher risk for preterm birth (Martin et al., 2019).
Research defining the relationship between urine samples and vaginal microbiome is
limited. It may not have been considered as an alternative to vaginal swabs because it was long
believed that the bladder and the urine within was sterile. This concept was perpetuated by the
inability to culture bacteria from urine (excluding bacteria responsible for urinary tract infections)
coupled with the now disproven belief that the presence of any bacteria in this region caused
harmful infection. Thus, it has been demonstrated conclusively that the bladder is not sterile
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(Brubaker et al., 2017; Thomas-White et al., 2016; Wolfe et al., 2012). A recent study focused on
the relationship of the urinary and vaginal microbiome found that “significant associations
between vaginal and urinary microbiomes were demonstrated, with Lactobacillus being
predominant in both urine and vagina. Abundance of other bacteria also correlated highly between
the vagina and urine (Komesu et al., 2020).” In addition to Lactobacillus, both body sites appear
to share significant abundances of Prevotella, Gardnerella, and Ureaplasma. Overall, this study
found that 60 of the top 100 most abundant operational taxonomic units shared an overlap in
abundance between the two microbiomes. Two taxa that were observed to be consistently unique
exclusive to the urinary microbiome were Tepidimonas and Flavobacterium. This study was not
sufficient for the context of our inquiry, as all of the urine from the women enrolled in the study
was acquired from catheterized samples. While this gives an accurate representation of the urinary
microbiome, urine that is collected before it freely exits the urethra and makes physical contact
with the vagina will not incorporate any species native to the vaginal microbiome. This point was
illustrated in a study focusing on the clinical implications of the urinary microbiome which found
that the microbiome profile generated from transurethral catheters and suprapubic aspirate
resembled each other closely while the bacteria in clean-catch mid-stream urines (a standard
operating procedure method that is used to avoid contaminating the urine sample with bacteria that
are normally present on skin and the epithelial layer in the urethra opening) resembled the bacteria
found in vaginal swabs. (Brubaker et al., 2017). Another study analyzed the changes in the urinary
microbiome during bacterial vaginosis and subsequent antibiotic treatment and compared the
microbiome profile generated from urine samples with profiles generated from vaginal fluid
samples collected at identical time points (Gottschick et al., 2017). They found that one community
type, referred to as Urotype-1, which was the largest community type of the 8 total assigned
Urotypes and characterized by large diversity and high relative abundance of the BV-associated
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OTUs Prevotella amnii, Sneathia amnii, Gardnerella vaginalis, and Atopobium vaginae,
demonstrated a positive correlation (59%) between the sample sets while the rest did not.
Current Study Aims
This study sought to answer three questions: (1) is the urinary microbiome significantly
different from the vaginal microbiome?; (2) can microbiome profiles generated from urine samples
be used to predict vaginal microbiome profiles with the hopes of adverse health conditions and
pregnancy outcomes including preterm birth?; (3) how can additional taxa unique to the urinary
microbiome be removed to generate a more accurate predictive model of the vaginal microbiome?
Various similarity and diversity analysis techniques were used to answer these questions. Alpha
diversity analysis was used to determine species richness within a single ecosystem. Three
different alpha diversity methods were employed: (1) Shannon Diversity Index, a weighted
mathematical measure of species richness in a community that takes both of the following methods
into account; (2) Evenness, the proportion and distribution of taxa in a sample; (3) Observed OTU,
the number of observed species in a sample. Beta diversity analysis is used to determine
dissimilarity between different ecosystems. One beta diversity method was employed: BrayCurtis, a statistical analysis that utilizes a fixed function to calculate clusters based on dissimilarity
which are then used to quantify compositional dissimilarity between different sites based on counts
at each site. Finally, a series of thresholds were applied to improve the linear relationships of taxa
abundance between vaginal and urine samples with the goal of creating a vaginal microbiome
predictive model that uses clean-catch urine as a proxy for vaginal swabs in future preterm birth
studies.
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Methods
Sample Collection and Selection
Samples for this study were selected randomly from a pre-existing cohort of volunteer
patients participating in the Multi-Omic Microbiome Study-Pregnancy Initiative (MOMS-PI).
MOMS-PI is a collaborative project funded by the NIH Roadmap Human Microbiome Project as
part of Phase 2 of the Integrative Human Microbiome Project (iHMP) that partners VCU with the
Global Alliance to Prevent Prematurity and Stillbirth (GAPPS). The goal of this project was to
improve our understanding of the relationship between the vaginal microbiome and pregnancy
with a specific focus on adverse outcomes including preterm birth. All samples in the cohort were
acquired throughout the course of the patients’ pregnancies. Eighty-four urine samples were
chosen from a list of patients who already had species-level microbiome profiles generated by
targeted 16S rRNA taxonomic surveys sourced from vaginal swabs collected at the same study
visit.
Samples acquired during MOMS-PI preterm birth study (Fettweis et al., 2019) were
collected at the enrollment visit, longitudinally during each prenatal visit, at triage, labor and
delivery, at discharge, and at postpartum follow-up visits. The samples in this study’s cohort were
selected from this sample set. Vaginal swabs were collected with BD BBL CultureSwab EZ swabs
from the mid-vaginal wall ~5 cm into the vagina. Swabs were collected either by healthcare
providers during pelvic exams or by self-sampling, which has been shown to provide samples
equivalent to those collected by trained clinicians. Patients were instructed by research
coordinators on self-sampling procedures and were provided an instructional brochure. All urine
samples were collected longitudinally using a clean-catch protocol in which the skin surrounding
the urinary opening is cleaned with sterile wipes, and urine is collected halfway through urination
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with special care not to physically touch the inside of the collection cup in order to prevent
contamination.
Urine DNA Extraction Protocol Establishment
Prior to DNA extraction on samples included in this study, an extraction protocol was
evaluated in order to determine the best technique to suit our needs. Urine samples from five
MOMS-PI study dropouts were selected. Five different techniques were used for DNA extraction:
1) 7.5 ml of whole urine was centrifuged for 1 minute at 10,000 x g and pelleted (eluant discarded),
then stored at -80º C; 2) 1.5 ml of whole urine was centrifuged for 1 minute at 10,000 x g and
pelleted (eluant discarded); 3) 50 µL of thawed urine; 4) 100 µL of thawed urine; 5) 250 µL of
thawed urine. The different extraction techniques are featured in a diagram below. All urine tested
for each patient sample derived from one large aliquot. Due to sample constraints, only three of
the analyzed sample sets contained thawed urine samples. Extractions were performed using
DNeasy PowerSoil kits (Qiagen) following the protocol as described by the manufacturer. All
DNA extractions, PCR, cleanup, qPCR, sequencing, and data curation were performed in identical
manner as described below in continuing sections of this method. The generated urine microbiome
profiles were compared to vaginal microbiome profiles generated from vaginal swabs collected on
the same day as the urine samples (due to sample constraints, the final sample set did not have a
vaginal swab microbiome profile with which to compare). There were fewer taxa observed in the
pelleted samples compared to the thawed samples. We hypothesize that some of the bacteria were
lysed and their DNA did not precipitate during the centrifugation. There was little observable
difference in the microbiota between the three thawed urine volumes and we elected to use 250
µL of thawed urine as the sample source for all future urine extraction protocols.
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(Extraction Protocol Diagram)

Sample Processing
Extractions were performed using DNeasy PowerSoil kits (Qiagen) following the protocol
as described by the manufacturer. 250 µL of thawed urine from each patient sample was pipetted
into Qiagen PowerBead Tubes, which contain approximately 200 µL of buffer that aids in
dissolving humic acids and protect nucleic acids from degradation, and vortexed briefly. 60 µL of
Solution C1, a solution that contains SDS and other disruption agents that ensure cell lysis as well
as the breakdown of fatty acids and lipids associated with cell membranes, was pipetted, briefly
vortexed manually, secured horizontally on a flat-bed vortex and vortexed at maximum speed for
15 minutes to ensure complete cell lysis. The tubes were centrifuged at 10,000 x g for 30 seconds,
supernatant (up to 500 µL) was transferred to a clean collection tube. 250 µL of Solution C2, a
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solution that precipitates non-DNA organic and inorganic material, was pipetted into each tube
and the tubes were briefly vortexed and incubated at 4º C for 5 minutes. The tubes were centrifuged
at 10,000 x g for 1 minute. 600 µL of supernatant was transferred to a clean collection tube. 200
µL of Solution C3, another solution to aid in precipitation of non-DNA organic and inorganic
material, was pipetted into each tube which were briefly vortexed and incubated at 4º C for 5
minutes. The tubes were centrifuged at 10,000 x g for 1 minute. 750 µL of supernatant was
transferred to a clean collection tube. 1.2 mL of Solution C4 was added to the tube and vortexed
for approximately 5 seconds. This adjusts the salt concentrations in the solution to allow the DNA
to bind to the spin filter in the proceeding step. Up to 675 µL of the DNA solution was added to a
spin filter and centrifuged at 10,000 x g for 1 minute. Flow through was discarded. This step was
repeated until all DNA solution was centrifuged through the spin filter. 500 µL of Solution C5, an
ethanol-based wash solution used to further clean DNA bound to the membrane, was added to each
tube and centrifuged for 30 seconds at 10,000 x g, removing any residual salt and other
contaminants from the bound DNA. After discarding the eluant from each tube, all tubes were
centrifuged at 10,000 x g one more time to remove any remaining liquid. After transferring the
spin tube to a fresh collection tube, 100 µL of DNAase-free H2O was pipetted directly onto the
spin filter and allowed to incubate for 1 minute at room temperature. Tubes were centrifuged for
30 seconds at 10,000 x g and flow through was stored at -20 C. The DNA concentrations from all
84 samples were measured using a NanodropTM 2000 Spectrophotometer. Confirmation of
amplifiable DNA was confirmed visually on 1% agarose gels after PCR using primers to amplify
the V1-V3 region of the 16s rRNA gene using a forward strand primer (5’AGAGTTYGATYMTGGCTYAG-3’

and

reverse

strand

primer

sequence

(5’-

ATTACCGCGGCTGCTGG-3’). The following parameters were used with the PCR reaction:
initial denaturation - 98º C for 30 sec for 1 cycle; denaturation - 98º C for 15 sec followed by
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annealing - 58º C for 15 sec followed by extension - 72º C for 15 sec for a total of 35 cycles; 72º
C for 60 sec. Each reaction was preparing with the following volumes: 3 µL of template DNA, 2
µL of each set of primers (forward and reverse), 10 µL of Phusion Master Mix (Thermofisher),
and 3 µL of H2O.
Barcoded PCR amplicons of bacterial 16S rRNA genes
Sequencing multiple samples simultaneously requires a means to identify each sample
individually as all samples are pooled prior to being loaded on the sequencer. In order to do this,
primers containing a variety of unique identifiable sequences are used during PCR to assign a
unique “barcode” sequence to each sample so they can be identified later during the demultiplexing
step. Barcode PCR was performed in a 96 well plate using the following parameters: initial
denaturation - 98º C for 30 sec for 1 cycle; denaturation - 98º C for 15 sec followed by annealing
- 58º C for 15 sec followed by extension - 72º C for 15 sec for a total of 35 cycles; 72º C for 60
sec. Each reaction was preparing with the following volumes: 2 µL of template DNA, 2 µL of each
set of primers (forward and reverse), 15 µL of Phusion Master Mix (Thermofisher), and 9 µL of
H2O. Sequences of the primers for the forward and reverse strand to amplify the V1-V3 region of
the 16S rRNA gene are shown below (“N” denotes a sample specific barcode sequence).
Forward Strand
5’-AATGATACGGCGACCACCGAGATCT-3’ (Flow cell binding primers)
5’-ACACTCTTTCCCTACACGACGCTCTTCCGATCT-3’ (binding sites for Illumina
sequencing primers)
NNNNNNNN (barcode)
NNNNNN (optional variable sequence spacer ranging from 0 or 3-6 nucleotides)
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5’-AGAGTTYGATYMTGGCTYAG-3’ (16S Primer)
Reverse Strand
5’-CAAGCAGAAGACGGCATACGAGAT-3’ (Flow cell binding primers)
NNNNNNNNNNNN (barcode)
5’-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT-3’ (binding sites for Illumina
sequencing primers)
5’-ATTACCGCGGCTGCTGG-3’ (16S Primer)

Library Processing
The amplicons with added barcodes were purified to remove all excess primers, salts, polymerase,
and other substrates. Ampure magnetic beads and PCR reactions were individually combined in
separate wells of a 96 well plate at a 1:1 ratio to select for DNA fragments larger than 100 bp. The
plate was incubated at room temperature for 10 minutes and placed on a magnetic plate, allowing
the beads and bound DNA to adhere to the sides of the plate which are in physical contact with the
magnetic force. The supernatant was carefully aspirated, leaving only the DNA which is bound to
the beads via electrostatic force. The beads were washed with 190 μL of 80% ethanol and allowed
to sit for 30 seconds before aspiration of the ethanol and any residual supernatant. This ethanol
wash step was repeated, and the plate was allowed to dry for 10 minutes at room temperature. 30
μL of 10 mM Tris-HCl (pH 8.0) buffer was added to each well and thoroughly mixed. The addition
of Tris lowers the ionic strength of the solution, allowing the DNA to detach from the magnetic
beads. The plate was allowed to incubate for 2 minutes before being very briefly centrifuged to
draw the Tris-DNA solution to the bottom of the wells. After placing the plate back on the magnetic
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rack, the supernatant was transferred to a new plate. As DNA sequencing requires a very high
nucleic acid purity, this cleanup was performed again in full to ensure that the amplified DNA
from the barcode PCR reaction was of sufficient quality.
The KAPA Library Quantification Kit (Illumina) was used to performed qPCR to
determine individual DNA concentrations of each sample. 6 µL of KAPA SYBR FAST qPCR
Master Mix (2X) + Primer Premix (10X) were combined with 4 µL of each sample, along with six
separate DNA standards needed to quantify concentration. The following parameters were used
with the qPCR reaction: initial denaturation - 95º C 5 min for 1 cycle; denaturation - 95º C for 30
sec followed by annealing/extension - 60º C for 45 sec for 35 cycles.
Based on qPCR results we diluted amplicon libraries to 4 nM in 10mM Tris-HCl (pH 8.0)
buffer and denatured with 0.2 N NaOH to create a equimolar pool. Denatured libraries were mixed
with Illumina hybridization buffer. PhiX Control v3, a standard Illumina sequencing control, was
used and loaded this mix to the MiSeq reagent cartridge. The cartridge was loaded into the
Illumina MiSeq System for sequencing.

Data Curation
Sequence data was separated by barcode and demultiplexed into sample paired-end FASTQ files
using a custom Python script All urine and the vaginal microbiomes samples with total reads less
than 10,000 were filtered out. Any samples removed as a result of this minimum-read threshold
resulted in the removal of their respective paired vaginal or urine microbiome sample as well,
which resulted in 75 sample pairs. To reduce the impact of statistical noise resulting from lowabundance values, the low-abundant taxa in this dataset were filtered out. We applied a threshold
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to remove the low-abundance taxa is a minimum of 1% relative abundance in at least 5% of all
samples or a minimum of 0.1% relative abundance in at least 15% of all samples, which resulted
in a total of 111 taxa for the following analysis.

Data threshold
The average sequencing depth of the 84 sample pairs of urine and vaginal microbiomes was
57,000 reads. All urine and the vaginal microbiomes samples with total reads less than 10,000
were filtered out. Any samples removed as a result of this minimum-read threshold resulted in
the removal of their respective paired vaginal or urine microbiome sample as well, which
resulted in 75 sample pairs. To reduce the impact of statistical noise resulting from lowabundance values, the low-abundant taxa in this dataset were filtered out. We applied a threshold
to remove the low-abundance taxa is a minimum of 1% relative abundance in at least 5% of all
samples or a minimum of 0.1% relative abundance in at least 15% of all samples, which resulted
in a total of 111 taxa for the following analysis.

Dissimilarity analysis
The reads table was normalized by rarefaction to the depth of 7040 reads, the lowest number of
total reads in these microbiomes after filtering, for use in the following diversity analysis. Alpha
diversity was quantified by calculating Shannon Diversity index, evenness and observed
operational taxonomic units (OTUs) using the vegan package in R (Dixon, P., 2003). The paired
Wilcoxon test was performed to test the significance of the alpha diversity between the paired
urine and vaginal microbiomes. Beta diversity was measured and visualized by a non-metric
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multidimensional scaling (NMDS) of Bray-Curtis distances. The significance of the dissimilarity
between the paired urine and vaginal microbiomes was tested by perMANOVA using adonis2 in
the vegan package in R (Dixon, P., 2003). The Bray-Curtis distance of a vaginal microbiome to its
paired urine microbiome was compared to the vaginal microbiomes of other persons and the
significance was calculated by Wilcoxon test.

Differential abundance test
The differential abundance of taxa in the paired urine and vaginal microbiomes was analyzed by
the ADLEx2 package in R (Fernandes et al., 2013). The reads table was normalized by the center
log ratio (CLR) transformation, followed by significance analysis using the paired Wilcoxon ranksum test. The abundance difference between the urine and the vaginal microbiome was evaluated
by the difference of the median CLR value.

Linear regression of taxa abundance
The linear regression of taxa abundance between the urine and the vaginal microbiome was
performed using the stats package in R to test whether the abundance of a taxon is predictable from
the urine microbiome to the vaginal microbiome. The p-value of the linear regression is corrected
using the Benjamini–Hochberg procedure with a false discovery rate (FDR) of 5%.
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Results
Diversity of community richness found in the vaginal and urine microbiomes
Alpha diversity was assessed to determine community richness and beta diversity was
assessed to determine dissimilarity between the urine samples and their respective paired vaginal
samples. Alpha diversity was analyzed using the Shannon Diversity Index, Evenness, and
Observed OTU. There was no statistically significant difference in Shannon Diversity Index (Fig.
1a) suggesting that the species distribution and proportion of taxa abundance in the urinary
microbiome is similar to the species distribution and proportion of taxa abundance in the taxa that
exist within the vaginal microbiome. The majority of the sample pairs exhibited similar Shannon
Diversity Indexes, although some pairs differed greatly (Fig S1a). The Observed OTU and
Evenness comparison showed statistically significant differences between sample pairs (Fig.
1b&c). Similar to the Shannon Diversity Index analysis, many of the sample pairs appeared to
have similar values of Evenness and total Observed OTUs while there were a number of sample
pairs that appeared to be very different in both measures (Fig S1b&c) On average, there were four
more taxa observed in the urine samples than in the vagina swab samples.
Dissimilarity between the vaginal microbiome and the paired urine microbiome
Analysis of the beta diversity of the urine and vaginal microbiomes demonstrated no
statistically significant difference (p=0.158) between the respective paired vaginal and urinary
microbiomes (Fig. 2a). Non-Metric Multi-Dimensional Scaling (NMDS) provides a way to
condense information from multidimensional data into a two-dimensional representation. It was
used here to visualize the Bray-Curtis Dissimilarity test results, which show a varying range of
dissimilarity between sample pairs, with many pairs distinctly clustered with low levels of
dissimilarity while a smaller number of others outside of the cluster exhibited higher dissimilarity.
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The low level of dissimilarity between vaginal and paired urine samples is emphasized in Fig. 2b
in which the Bray-Curtis Distance between vaginal and paired samples is shown to have a much
lower level of dissimilarity compared to the dissimilarity between vaginal samples. This
demonstrates that the vaginal microbiomes of each study participant are more similar to their
respective paired urine microbiome than to the vaginal microbiomes of the other study volunteers.
The Bray-Curtis Distance of individual sample pairs is shown in Fig. 2c. Much like the NMDS
plot, a large range of diversity is demonstrated among the entire sample set. Over half of paired
samples exhibited a low level of Bray-Curtis distance which would indicate that most taxa called
within one sample set (i.e. vaginal) would be found in their paired sample set (i.e. urine). A
minority of the sample pairs, however, exhibited a high level of dissimilarity, indicating that very
few taxa are shared between those sample pairs. This large range of beta diversity can be seen
additionally in the assigned vagitypes of the vaginal samples and their paired urine samples (Fig.
2d). Vagitypes, which is a term used often used to describe a community state type that helps
differentiate vaginal microbiomes, are based on taxon that represent at least 30% of a total number
of reads analyzed in a sample. Samples lacking a taxon that comprises at least 30% of the
proportional abundance are assigned a ‘no-type’ vagitype. Fifty-three of the total seventy-five
paired samples shared the same vagitype.
Comparing microbiome profiles from multiple body sites
Evaluating the relationship between the microbiome of multiple body sites helps to provide
context of dissimilarity. Partial Least Squares Discriminant Analysis (PLS-DA), a dimension
reduction technique that helps to determine which features/variables best discriminate amongst
groups of interest, was applied to four sample sets, including swabs from rectal and buccal samples
from the respective patients collected on the same day as the urine and vaginal samples (Fig. 3a).
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The PLS-DA analysis illustrates the similarity of the microbiome community data generated for
urine samples and vaginal samples when compared with the two other body sites. While there is
some overlap between all four body sites, the urine samples have a nearly complete overlap with
the vaginal samples. Multidimensional scaling analysis, a nonparametric technique used to
visualize dissimilarity, illustrates a closer relationship between urine and vaginal microbiome
profiles with less separation between these two sites compared to rectal and buccal swab samples
(Fig. 3b). These two plots demonstrate that the vaginal microbiome is much more similar to the
urinary microbiome than it is to the microbiomes of the buccal or rectal regions.
Taxon Abundance in the Microbiome Profiles of Urine and Vaginal samples
The paired urine and vaginal microbiome profiles demonstrated a distinct overlap of top
percentage taxa observed (Fig. 4a). Eight of the top nine most abundant species on average in the
vaginal samples were all found to be the most abundant species in the urine samples. The
noticeable outlier in the urine samples was Enterobacteriaceae cluster31, the abundance of which
comprised the majority of the microbiome community in five of the urine samples. This taxon was
notably absent in the vaginal samples. The taxa Propionibacterium acnes, Streptococcus
salivarius_thermophilus_vestibularis, Staphylococcus cluster47, Lactobacillus jensenii, and
Enterobacteriaceae cluster31 were also found to be significantly more abundant in urine samples
along with four taxa below the 97% identity threshold that were closely related to Staphylococcus
cluster47,

Streptococcus

salivarius_thermophilus_vestibularis,

Lachnospiraceae BVAB1 and Enterobacteriaceae cluster31,

Streptococcus

cluster29,

Prevotella disiens, Sneathia

sanguinegens, Finegodlia magna, Dialister micraerophilus, Prevotella cluster2, and Sneathia
amnii were found to be enriched in the vaginal microbiome, although at much lower levels
compared to the enrichment found in the unique bacterial taxa (Fig. 4b). The difference in

23

abundance in these taxa across individual patient samples is visualized in Fig. 4c.
Enterobacteriaceae cluster31 was the most uniquely over-abundant taxon in urine which exhibited
an abundance over ten-fold higher than in vaginal samples. Urine samples dominated by this taxon
exhibited a significantly greater level of dissimilarity with their respective vaginal pairs compared
to all other sample pairs (Fig. S3). It was less common for a taxa to be observed in the vaginal
microbiome but absent in their paired urine sample. This is consistent with the results of the
Observed OTU results (Fig. 1c) that showed that the urinary microbiome found in clean-catch
urine has a greater number of observed taxa than the vaginal microbiome. Notable outlying taxa
present in the urinary microbiome but absent or rare in the vaginal microbiome include:
Enterobacteriaceae

cluster31,

Streptococcus

salivarius_thermophilus_vestibularis,

Propionibacterium acnes, and Streptococcus parasanguinis.
As one of the objectives of this study was to determine whether or not urine could be used
as a proxy for the vaginal microbiome in order to use it to predict risk of adverse outcomes,
including for example preterm birth, it was important to understand the dissimilarity between the
urine and vaginal microbiome. Once we understand this relationship, the urine could be used to
provide an accurate prediction of the microbiota in the vagina. Since we have previously identified
taxa associated with preterm birth, and four taxa—Sneathia amnia, TM7 OTU-H1, Prevotella
cluster2, and Lachnospiraceae BVAB1—were used to generate a model predicting preterm birth,
we examined the association of these taxa in urine and vaginal samples. Thus, it was not gratifying
that all four species had a positive linear relationship of relative abundance when sample types
were compared (Fig. 5). Other species that have been associated in other studies with increased
risk of preterm birth—Atopobium vaginae, Megasphere cluster52, Mobiluncus curtsii,
Molbiluncus mulieris, Porphyromonas uenonis_asaccharolytica, Sneathia sanguinegens,
Gardnerella vaginalis, Dialister cluster51, Prevotella bivia, and Dialister micraerophilus—also
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had positive linear relationships between vaginal and paired urine samples (Table 1). Two
additional species noted in a previous study (Elovitz et al., 2019)—Mageeibacillus indolicus and
Prevotella buccalis—were not among the taxa observed in any samples from our cohort, whether
from the vagina or urine.
Using the urine microbiome profiles to predict corresponding vaginal microbiome profiles
In order to improve the prediction of the vaginal microbiome using urine samples, we
applied three additional thresholds to the sample sets. The first threshold filtered out any taxa that
had a 5-fold higher statistical chance of appearing in urine samples in comparison to vaginal
samples. The second threshold filtered any taxa with a 10-fold higher abundance in urine samples
than vaginal. Propionibacterium acnes, Streptococcus salivarius_thermophilus_vestibularis,
Enterobacteriaceae cluster31, which appeared to be the dominating taxa in several urine samples,
and three taxa below the 97% identity threshold closely related to Streptococcus
salivarius_thermophilus_vestibularis, Enterobacteriaceae cluster31, and Streptococcus cluster29
were the six taxa removed as a result of these new thresholds. As the removal of the taxa from the
previous thresholds reduced overall total read count for certain samples, the original threshold of
a minimum of 10,000 reads was reapplied. This reduced the number of sample pairs from seventyfive to sixty-eight. This new data set with 105 total taxa was analyzed with a focus on taxa
correlated with increased risk of preterm birth.
After the removal of the six outlying taxa found to be enriched exclusively in the urine
samples, the difference in alpha diversity between the vaginal and paired urine microbiomes was
reduced significantly (Fig. S4). Namely, the calculated Evenness for both sample sets were much
closer, showing no significant difference (P = .218) which is a stark contrast from previous results
which showed significant difference in Evenness (Fig. 1b). Both Shannon Diversity Index (P =

25

.601) and Evenness showed no significant difference after these taxa were removed which
indicates that the community richness seen in urine samples were closely related to that seen in
vaginal samples. The Observed OTU still showed significant difference (P = .001) but this was to
be expected as there were still a greater number of taxa found in the urine samples.
Removal of the outlying urine taxa also showed a significant reduction in dissimilarity
between the vaginal and paired urine samples as evidenced by reanalysis of Beta Diversity. There
were fewer distant pairs observed on the Bray-Curtis NMDS plot (Fig 6a) compared to the original
plot (Fig 2a), resulting in less significant difference of Beta Diversity between paired samples (P
= .253 compared to P = .158). This also resulted in greater separation seen in the Bray-Curtis
distance of the vaginal samples and their paired urine samples and the Bray-Curtis distance
between all vaginal samples (Fig 6b), showing that the vaginal microbiomes are even more similar
to their paired urine microbiomes than to the vaginal microbiomes of other study participants once
the taxa are removed (P = 8.12E-25 compared to P = 1.5E-20). A noticeable reduction in sample
pairs with high Bray-Curtis distance can also be seen in Fig. 6c. Not surprisingly, the samples
removed as a result of the threshold were among those with the highest levels of beta diversity.
This is reflected in the assigned vagitypes (Fig. 6d) of the vaginal and urine samples as all seven
sample pairs removed did not have matching vagitypes. Prior to the removal of the six taxa
described above, every urine microbiome dominated by Enterobacteriaceae cluster31 had a
different vagitype compared to its paired vaginal microbiome (Fig 2d). After removing the four
taxa, the vagitype of those samples perfectly matched the paired vaginal sample vagitype,
demonstrating that Enterobacteriaceae cluster31 impacts the prediction of vagitype in the vaginal
microbiome and that the clean-catch urine can reliably predict vagitype.
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The taxonomical abundance profiles of the vaginal and urine microbiomes appeared to be
more similar after the removal of the skewing taxa. Previously, eight of the nine top most abundant
taxa were shared between both sample sets while Enterobacteriaceae cluster31 was the lone
unique taxa in urine that appeared to dominate several samples. After their removal, the nine top
abundant taxa in the vaginal microbiota samples were shown to be the top nine abundant taxa in
urine microbiota samples (Fig 7a). Additionally, the number of taxa differentially enriched
exclusively in either urine or vaginal samples was reduced from ten taxa to four—Lactobacillus
jensenii, Staphylococcus cluster47, and two taxa below the 97% identity threshold but closely
related to: Staphylococcus cluster47, Lachnospiraceae BVAB1—in the urine and seven taxa to
one—Prevotella cluster2—in the vaginal microbiota.
The linear relationship of relative abundance of the four taxa used to create a predictive
model for preterm birth improved further as the correlation coefficient increased for each taxon
between sample pairs (Fig. 8). Additionally, all taxa that have been associated with increased risk
of preterm birth that were identified in our cohort has increased positive linear relationships of
relative abundance (Table 1). This data suggests that urine samples can be used to predict the
occurrence of these taxa in the vaginal microbiome.
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Discussion
The objective of this study was to determine whether the microbiome profile generated
from clean-catch urine samples can be used as a proxy for the vaginal microbiome and, in
particular, if it can accurately predict the four taxa—Sneathia amnia, TM7 OTU-H1, Prevotella
cluster2, and Lachnospiraceae BVAB1—previously shown to be associated with increased risk of
preterm birth.
Alpha and Beta Diversity analysis both demonstrated that there is no statistically
significant difference between the generated microbiome profiles from vaginal swabs and cleancatch urine samples. Bray-Curtis distance analysis revealed that the vaginal microbiome has a
significantly lower level of dissimilarity to its paired urinary microbiome in comparison to the
vaginal microbiomes of other women. Additionally, the prediction of the vaginal microbiome from
clean-catch urine can be improved by removing outlying taxa found to have a statistically more
significant chance of existing only in urine samples through several thresholds. These data suggest
that using clean-catch urine can provide a reliable and accurate prediction of the vaginal
microbiome. Moreover, four taxa previously associated with preterm birth which were used to
create a predictive model;

i.e., Sneathia amnia, TM7 OTU-H1, Prevotella cluster2, and

Lachnospiraceae BVAB1 could be accurately measured. Overall, the results suggest that the urine
microbiome can be useful as a proxy for the vaginal microbiome.
In this study, we observed a significantly higher numbers of species in the urine than the
vagina. Additionally, several taxa have much higher abundance in the urine than the vagina.
Because urine passes through and makes physical contact with the bladder, urethra, and finally the
vagina, it is reasonable to surmise that the urine microbiome contains more taxa than the vaginal
microbiome. It is difficult to determine, however, if some of these taxa found almost exclusively
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in the urine truly exist as part of the urinary microbiome or have extrinsic origins. The most
significant of these taxa is Enterobacteriaceae cluster31, which was the dominating taxa in five
separate urine samples. The Enterobacteriaceae family includes several taxa including E. coli,
which is the most common source of urinary tract infections (Minardi et al., 2011). As this
overwhelmingly-dominant taxa was only found in urine samples, we hypothesize that the origin
of this taxa may come from undiagnosed urinary tract infections in these five patients. This would
indicate that the bacteria responsible for UTIs can contaminate clean-catch urine samples and
obscure the actual vaginal microbiome profile. Although the Enterobacteriaceae are also common
in stool samples, indicating possible fecal origin as well, fecal contamination would usually consist
of a broad spectrum of gut-specific taxa (Tang et al., 2020). Since these were not observed, we
assume that the most likely explanation for the presence of the Enterobacteriaceae is from
undiagnosed urinary tract infection.
Several other taxa that were found to have a significantly higher chance of occurring solely
in urine rather than vaginal samples are also hypothesized to have contaminant origins from other
body sites. Propionibacterium acnes is a gram-positive human skin commensal that is involved in
the pathogenesis of acne (Institute of Medicine Forum on Microbial Threats, 2009). A previous
study that examined the relationship of the urinary and vaginal microbiomes using catheterized
urine samples found no bacteria from the Propionibacterium genus in the bladder (Komesu et al.,
2020) suggesting that this taxa appearing in the clean-catch urine samples may have come
inadvertent skin contamination occurring during sample collection. As the urine samples in this
study were collected by the study participants themselves, the room for error in sterile technique
practice cannot be discounted. Additionally, Streptococcus salivarius and Streptococcus
vestibularis, which are grouped in the Streptococcus salivarius_thermophilus_vestibularis cluster
due to the fact that their V1-V3 region DNA sequences are nearly identical, are common members
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of the normal human oral microflora. As these taxa are not usually abundant in the vaginal
microbiome nor are they associated with the urinary microbiome (Ackerman & Chai, 2019;
Neugent et al., 2020), we presume that they are contaminants possibly resulting from oral contact
or oral sex. Alternatively, respiratory droplets resulting naturally when breathing, coughing,
sneezing, or speaking could provide a means for these taxa to reach the collection cup. It is
important to note that Streptococcus salivarius has been isolated from human bacteremia in rare
cases, so that source should not be discounted. While the taxonomical identification of the
Streptococcus cluster29 was below the 97% identity threshold, many species belonging to this
Gram-Positive genus are fairly ubiquitous and can be found in numerous body sites and in the
environment. They are not, however, considered to be traditionally associated with the urinary or
vaginal microbiome. After the removal of these six taxa as seen in Fig. 5 and 6, the urinary
microbiome was far more similar to the respective vaginal microbiome in all sample sets,
demonstrating how crucial this step is in creating a reliable method of using clean-catch urine
samples to predict the vaginal microbiome.
Alpha and beta diversity analysis demonstrated similarity in the paired microbiomes. Alpha
diversity, which can be associated with intra-sample analysis of community richness, provides
statistical analysis on the proportional abundance observed within individual communities. The
results from Shannon Index Diversity analysis, which is a weighted analysis of taxa distribution
and often considered to provide the most comprehensive analysis of alpha diversity, showed that
there is no statistical difference between the microbiome profile generated from urine samples as
compared to their paired vaginal samples (Fig 1a). Evenness, another similar alpha diversity
analysis technique, yielded similar results that reinforced the conclusion that the differences in
proportions of taxa in each community were not statistically significant (Fig 1b). The third alpha
diversity analysis technique used was Observed OTU, a simple metric that assesses community
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diversity based solely on the number of taxa called for each sample, showed significant statistical
difference between sample pairs (Fig 1c). This result was not surprising however considering that
there were more unique taxa in very small abundances observed in the urine samples. Utilizing
several statistical thresholds later in the analysis to remove taxa not found in vaginal samples
negated this challenge.
Bray-Curtis Dissimilarity beta diversity analysis suggested that there were no statistically
significant differences between sample pairs (Fig 2a). Close examination of the data reveals that
the dissimilarity varies, with many pairs clustering together while others appear to be very
dissimilar as their pairs are spread at a greater distance across the plot. This is verified in Fig. 2c
which shows that over half of all sample pairs have a dissimilarity value less than 25% while a
minority of sample pairs have a dissimilarity value over 50%. It is important to note that this latter
group includes the five urine samples that were dominated by likely urinary tract pathogens (e.g.,
E. coli) in Enterobacteriaceae cluster31. This observation suggests that many of the sample pairs
are statistically similar, and only a small proportion of the sample data set is influencing the overall
dissimilarity seen in beta diversity analysis as seen in Fig. S3. Regardless of these skewing pairs,
analyzing the dissimilarity between urine and their paired vaginal samples compared to
dissimilarity strictly between vaginal samples shows that the average Bray Curtis dissimilarity
value of the urine-vaginal samples is notably lower than vaginal-vaginal in addition to much a
smaller error bar range (Fig 2b). This indicates that the low level of dissimilarity between urine
and paired vaginal samples is statistically significant and that the vaginal microbiome has more
similarity to the microbiome profile generated from clean-catch urine than it does compared to the
vaginal microbiome from other study participants.
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The species distribution and diversity in these samples is often used to divide vaginal
microbiomes into community state types called vagitypes, which are based on taxa that comprise
at least 30% of total species abundance. Vagitypes are a convenient method used in clinical
research settings that simplify classification and can be used to quickly place patients into different
risk-level assessment groups depending on the health disparity. As seen in Fig. 2d, there are several
distinct clusters, with L. iners as the predominant vagitype. Notably, all of the Enterobacteriaceae
cluster31 vagitypes differ from their paired vaginal vagitype. In total, 53 of 75 total sample pairs
have matching sample types.
An important aspect when comparing both sample sets is the context of other body sites.
This broader perspective is relevant when comparing microbial ecosystems that have inevitable
overlap as well as unique differences in composition. While Bray-Curtis NMDS plots are helpful
in visualizing dissimilarity, it is difficult to determine the how close of a relationship exists
between the two sample sets based on visual graphics. Including two other body sites, e.g., buccal
and rectal, in PLS-DA and NMDS analysis (Fig. 3) allows us to visually ascribe a reasonable
context when looking at the clusters. While the PLS-DA analysis shows minimal overlap between
all four sample sets, urine and vaginal samples are largely overlapped when compared with the
other two. The rectal sample cluster is considerably closer to urine and vaginal than buccal, which
can be expected due to its close proximity on the human body. The NMDS analysis shows a very
similar result, but far more pronounced as the urine cluster exists entirely within the vaginal cluster,
while the buccal cluster is much further than in the PLS-DA analysis and has no overlap with
clusters from any of the other body sites. While this does not confirm any aspect of the relationship
between the urine and vaginal microbiome, it shows that the vaginal microbiome is much closer
to the microbiome found in clean-catch urine than buccal or rectal body sites.
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In order to improve the relationship between the paired microbiomes, several statistical
thresholds removed six taxa that were found to have an abundance ten folder higher or have a
significantly higher chance of existing in the urinary microbiome. The taxa removed were
Propionibacterium

acnes,

Streptococcus

salivarius_thermophilus_vestibularis,

Enterobacteriaceae cluster31, and three taxa below the 97% identity threshold closely related to
Streptococcus

salivarius_thermophilus_vestibularis,

Enterobacteriaceae

cluster31,

and

Streptococcus cluster29. Samples falling below the 10,000-minimum read threshold as a result of
the removal of these taxa were removed. The additional filtration and removal of these taxa found
to be enriched in the urine samples had a significant impact on the relationship of the paired
microbiomes and made them considerably more similar.
Alpha and beta diversity demonstrated that the paired microbiomes became more similar
regarding their community richness and diversity of taxa within those ecosystems once the
skewing taxa were removed (Fig S4 & 6a-c). Some of these changes can be seen in the generated
microbiome profiles for both urine and vaginal samples, which provides a general overview of the
composition of each sample. Prior to the removal of the taxa, it is important to note that eight of
the most abundant taxa in the vaginal samples are shared as the top abundant taxa in the urine
samples (Fig 4a). The one outlier that dominated several urine samples, which has been noted
several times throughout, was Enterobacteriaceae cluster31. Once the skewing taxa were
removed—notably Enterobacteriaceae cluster31—the top nine most abundant taxa in the urine
samples matched those in the vaginal samples (Fig 7a). The number of taxa found enriched
exclusively in either the vaginal or urinary microbiota were also greatly reduced from 17 taxa to 5
total (Fig 7b). The only vaginal taxa remaining—Prevotella cluster2—is an important one as it is
implicated in the predictive model of preterm birth. As evidenced in Fig.s 5 and 8, however, the
increased level of enrichment in the vagina still demonstrates a positive linear relationship between
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the abundance of this taxa in both sample sets. Lactobacillus jensenii, Staphylococcus cluster47,
and two taxa below the 97% identity threshold but closely related to Staphylococcus cluster47 and
Lachnospiraceae BVAB1, respectively, still remained to be enriched at higher levels in the urine.
Lactobacillus jensenii has recently been identified as a regular member of both the urinary and
vaginal microbiome (Rivera et al., 2020). While it appears here to be enriched more in the urine,
it still exhibits a very linear relationship of relative abundance between both body sites with the
fifth highest correlation coefficient of all shared taxa (Table 1). As Staphylococcus species are
commonly found on the epidermis, we hypothesize that the two Staphylococcus-cluster origins
from skin contact during the urine collection process. It is interesting that the taxa below-thethreshold but related to Lachnospiraceae BVAB1 would be enriched in the urine as BVAB1 is
associated with the vaginal microbiome and implicated in increased risk of preterm birth,
especially considering the taxa identified above the threshold as Lachnospiraceae BVAB1 was not
differentially enriched in either sample sets. As this taxa is below the threshold, it is difficult to
determine its biological significance. However, it is important to note that it still had a moderately
positive linear relationship of relative abundance between body sites.
The thresholds aided in removing mismatched vagitypes as well. Initially, all urine
microbiomes dominated by Enterobacteriaceae cluster31 (Fig. 4) were assigned to that specific
vagitype which differed from their paired vaginal sample vagitypes. After removing the four taxa,
all urine samples originally assigned to the Enterobacteriaceae cluster31 were reassigned to
vagitypes that matched their paired vaginal sample vagitype (Fig. 6d), demonstrating that the
urinary microbiome can reliably predict the vagitype (~79% accuracy).
One goal of this study was to determine if urine can be used as a proxy for the vaginal
microbiome and, more importantly, if it can reliably predict the occurrence and abundance of the
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four taxa used in the predictive model of increased risk of preterm birth. The relative abundance
of Sneathia amnia, TM7 OTU-H1, Prevotella cluster2, and Lachnospiraceae BVAB1 from the
original data had positive linear relationships (Fig. 5). We wanted to create a method to generate
a more reliable prediction of the vaginal microbiome though so removing taxa that skewed this
relationship was an important step. After removing the six top skewing urinary taxa from the
microbiome profiles, these linear relationships improved even further indicating that the
abundance of these taxa found in clean-catch urine can be used to accurately predict their
abundance in the vaginal microbiome (Fig 8). It is very important to note in the Lachnospiraceae
BVAB1 linear regression plot, however, that there are two distinct clusters, one at high abundance
and one at lower abundance. Fig 4c provides some explanation as this taxa appeared to have less
consistency than the other three taxa in the preterm birth predictive model; it appeared in some of
the vaginal samples but not their paired urine samples and conversely, it appeared in a larger
number of urine samples but not their paired vaginal sample. Additionally, all four plots contain
data points implying zero abundance. While many of the samples pairs were shown to lack any
abundance of these taxa, the sample pairs which include abundance at only one of the two body
sites would mean that some of these zero-abundance data points would have no correlation to data
point of their paired sample. All other taxa associated with preterm birth in other studies that were
found in our cohort—A. vaginae, Megasphere cluster52, M. curtsii and mulieris, P.
uenonis_asaccharolytica, S. sanguinegens, G. vaginalis, Dialister cluster51, P. bivia, and D.
micraerophilus—also showed statistically significant positive linear relationships regarding
relative abundance of these taxa found in vaginal and urine microbiota (Table 1). These results
indicate that using clean-catch urine samples while including only the remaining 105 taxa in future
vaginal microbiome profile generation and preterm birth risk analysis is a viable alternative to
vaginal swabs.
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Implications
The findings of the current study suggest that microbiome profiles generated from urine
samples can provide an accurate representation of the vaginal microbiome. Including the use of
urine samples in MOMS-PI preterm birth study as part of the integrative Human Microbiome
Project would allow for ease of sample collection and a larger sample population. This would
increase the knowledge base surrounding increased risk of various health implications, including
but not limited to bacterial vaginosis, sexually transmitted infections, and preterm birth, which will
hopefully allow for prophylactic, rather than remedial measures to be taken.

Conclusion
There are currently no alternative sampling techniques of the vaginal microbiome to
relatively invasive vaginal swabs. Using clean-catch urine samples would provide a less invasive
sampling technique and access to a greater number of samples, often using samples collected in
and left over from samples collected in standard clinical practice. The results from this study
demonstrate that the microbiome profile generated from urine samples is a reliable proxy to their
paired vaginal samples. By identifying taxa found in urine that are not shared by vaginal samples,
we were able to circumvent skewing data allowing us to focus on taxa of interest, thus yielding a
faithful surrogate profile of the vaginal microbiome and an accurate prediction of taxa abundance
of Sneathia amnia, TM7 OTU-H1, Prevotella cluster2, and Lachnospiraceae BVAB1 which will
aid in future studies on the connection between the vaginal microbiome and preterm birth.
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Figures

Figure 1: Alpha diversity analysis of urine and vaginal samples. (a) Shannon Diversity Index
alpha diversity analysis of paired vaginal-urine samples. P = 0.29699 indicates no significant
difference between sample pairs. (b) Evenness alpha diversity analysis of paired vaginal-urine
samples. P = 0.046217 indicates a significant difference between sample pairs. (c) Observed
OTU alpha diversity analysis of paired vaginal-urine samples. P = 0.000571 indicates a
significant difference between sample pairs.
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Figure S1: Alpha diversity analysis of paired urine and vaginal samples. (a) Shannon
Diversity Index alpha diversity analysis of paired vaginal-urine samples. Lines denote individual
sample pairs. P = 0.29699 indicates no significant difference between sample pairs. (b) Evenness
alpha diversity analysis of paired vaginal-urine samples. Lines denote individual sample pairs. P
= 0.046217 indicates a significant difference between sample pairs. (c) Observed OTU alpha
diversity analysis of paired vaginal-urine samples. Lines denote individual sample pairs. P =
0.000571 indicates significant difference between sample pairs.
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Figure 2: Beta Diversity analysis of paired urine and vaginal samples. (a) NMDS plot of
Bray Curtis Dissimilarity beta diversity analysis of urine and vaginal samples. Lines denote
individual sample pairs. P = 0.158 indicates no significant difference between vaginal and urine
sample pairs. (b) Bray-Curtis distance of Vaginal vs Vaginal compared to Vaginal vs Paired
urine. P < 1.5E-20 indicates significant difference. The data was subjected to CLR normalization
(see Methods). (c) Bray Curtis Distance of paired urine and vaginal samples. Each bar represents
the distance of one individual sample pair. (Distance of 0 indicates no dissimilarity and all
species shared. Distance of 1 indicates 100% dissimilarity and no shared species.) (d) Vagitypes
of urine and paired vaginal samples. 53 of 75 sample pairs have matching vagitypes.
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Figure 3: Dissimilarity of microbiomes by body site. (a) PLS-DA plot of sample clusters from
buccal, rectal, urine, and vaginal samples from the same individual. (b) NMDS plot comparing
dissimilarity of the same samples.

`
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Figure 4: Taxa abundances in vaginal and urine microbiome profiles. (a) Generated
microbiome profiles lined up in in order of decreasing Lactobacillus iners abundance in the
vaginal microbiome and the paired samples in the urine microbiome are shown in the same order
as their respective paired sample above. Top 9 abundant taxa shown for each sample set. (b)
Species found to be the most statistically significant difference in abundance by body site. Data
acquired via Mann-Whitney U Test after CLR normalization. (c) Shared and unique taxa
presence in urine and vaginal samples. Arrows denote taxa demonstrated to be enriched uniquely
in the urine samples that were removed after the application of two thresholds: (1) filtered out
any taxa that had a 5-fold higher statistical chance of appearing in urine samples in comparison
to vaginal samples; (2) filtered any taxa with a 10-fold higher abundance in urine samples than
vaginal. Taxa removed: Propionibacterium acnes, Streptococcus
salivarius_thermophilus_vestibularis, Enterobacteriaceae cluster31, Streptococcus
salivarius_thermophilus_vestibularis BT, Enterobacteriaceae cluster31 BT, and Streptococcus
cluster29 BT.

Fig. S3
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Figure S3: PLSDA on abundances of paired vaginal and urine samples. Analysis separates
sample pairs according to increasing levels of dissimilarity. Outlier urine samples dominated by
Enterobacteriaceae cluster31 represented in the top cluster circled in red. Respective paired
vaginal samples represented in lower cluster circled in red.
`

Figure 5: Linear regression analysis of taxa abundance in urine and vaginal samples. The
linear relationship of the relative abundances in urine and vagina of the four taxa associated with
predictive model of preterm birth. The stats package in R was used to model a continuous
variable (taxa abundance in the vagina) as a mathematical function of one variable (taxa
abundance in the urine) so that this regression model can be used to predict the abundance of the
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taxa in the vagina when only the abundance in urine is known. The p-value of the linear
regression is corrected using the Benjamini–Hochberg procedure with a false discovery rate
(FDR) of 5%, which is used to account for the expected proportion of type I errors in which an
incorrect rejection of the null hypothesis is made resulting in a false positive. (Lachnospiraceae
BVAB1: R = 0.6314, Adj-P = 1.68E-15; TM7 OTU-H1 : R = 0.6117, Adj-P = 1.09E-14; Sneathia
amnii: R = 0.6371, Adj-P = 9.59E-16; Prevotella cluster2: R = 0.5051, Adj-P = 7.16-11).

Figure S4: Alpha diversity analysis of urine and vaginal samples after the removal of six
taxa. (a) Shannon Diversity Index alpha diversity analysis of paired vaginal-urine samples. P =
0.601 indicates no significant difference between sample pairs. (b) Evenness alpha diversity
analysis of paired vaginal-urine samples. P = 0.218 indicates no significant difference between
sample pairs. (c) Observed OTU alpha diversity analysis of paired vaginal-urine samples. P =
0.001 indicates a significant difference between sample pairs.
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Figure 6: Beta diversity analysis of urine and vaginal samples after the removal of six taxa.
(a) NMDS plot of Bray Curtis Dissimilarity beta diversity analysis of urine and vaginal samples.
Lines denote individual sample pairs. P = 0.158 indicates no significant difference between
sample pairs. (b) Bray-Curtis distance of Vaginal vs Vaginal compared to Vaginal vs Paired
urine (P < 1.5E-20). Data subjected to CLR normalization. (c) Bray Curtis Distance of paired
urine and vaginal samples. Each bar represents the distance of one individual sample pair.
(Distance of 0 indicates no dissimilarity and all species shared. Distance of 1 indicates 100%
dissimilarity and no shared species.) (d) Vagitype of urine and paired vaginal samples. 53 of 75
sample pairs have matching vagitypes.
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Figure 7: Taxa abundances in vaginal and urine microbiome profiles after the removal of
six taxa. (a) Generated microbiome profiles after additional thresholds removed six taxa which
were found to be heavily enriched in the urine samples. Samples are lined up in same sample
order as previous graph (originally in decreasing Lactobacillus iners abundance). Top 9
abundant taxa shown for each sample set. (b) Species found to be the most statistically
significant difference in abundance by body site. Data acquired via Mann-Whitney U Test after
CLR normalization.
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Figure 8: Linear regression analysis of taxa abundance in urine and vaginal samples after
the removal of six taxa. The linear relationship of the relative abundances in urine and vagina of
the four taxa associated with predictive model of preterm birth improve after the removal of six
outlying urine taxa. The p-value of the linear regression is corrected using the Benjamini–
Hochberg procedure with a false discovery rate (FDR) of 5%. (Lachnospiraceae BVAB1: R =
0.6522, Adj-P = 7.50E-15 ; TM7 OTU-H1 : R = 0.6711, Adj-P = 1.21E-15 ; Sneathia amnii: R =
0.7125, Adj-P = 1.46E-17 ; Prevotella cluster2: R = 0.5610, Adj-P = 1.61E-11).

51
Tables

Taxa
Actinomycetales OTU158
Aerococcus christensenii
Aerococcus christensenii BT
Alloscardovia omnicolens
Anaerococcus hydrogenalis
Anaerococcus lactolyticus_cluster
Anaerococcus OTU145
Anaerococcus OTU147
Anaerococcus tetradius
Atopobium vaginae
Atopobium vaginae BT
Bacteroides coagulans
Brevibacterium ravenspurgense
Bulleidia OTU94
Campylobacter hominis
Campylobacter ureolyticus
Clostridiales BVAB2
Clostridiales BVAB2 BT
Clostridiales BVAB3 BT
Clostridiales OTU22
Clostridiales OTU22 BT
Coriobacteriaceae OTU27
Coriobacteriaceae OTU27 BT
Corynebacterium aurimucosum_nigricans
Corynebacterium cluster45
Corynebacterium cluster45 BT
Corynebacterium cluster58
Corynebacterium cluster58 BT
C. imitans_lipophiloflavum BT
Corynebacterium simulans_striatum
Corynebacterium thomssenii_sundsvallense
Dialister cluster51
Dialister cluster51 BT
Dialister micraerophilus
Dialister micraerophilus BT
Dialister propionicifaciens
Enterobacteriaceae cluster31
Enterobacteriaceae cluster31 BT
Enterococcus faecalis

Before taxa removal
After taxa removal
Rp-value value
adj_p
p-value
R-value
adj_p
6.78E-06 0.2437 0.000176 8.38E-05
0.2103
0.001341
5.18E-17 0.6204 4.82E-15 6.17E-19
0.7004
5.61E-17
5.55E-06 0.2477 0.00015 3.00E-05
0.2334
0.000601
3.18E-27 0.8000 3.43E-25 3.93E-22
0.7600
3.74E-20
1.85E-10 0.4288 1.26E-08 1.53E-09
0.4271
8.55E-08
1.35E-07 0.3183 5.95E-06 5.15E-08
0.3641
2.18E-06
6.54E-09 0.3714 3.73E-07 1.28E-10
0.4679
7.93E-09
7.68E-17 0.6163 7.06E-15 1.29E-17
0.6717
1.15E-15
6.27E-10 0.4098 3.82E-08 1.63E-07
0.3420
5.72E-06
1.09E-18 0.6583 1.07E-16 7.45E-19
0.6987
6.71E-17
1.28E-13 0.5308 1.05E-11 1.45E-12
0.5346
1.04E-10
2.26E-07 0.3090 9.48E-06 8.24E-08
0.3552
3.21E-06
1.54E-07 0.3160 6.60E-06 2.51E-08
0.3775
1.18E-06
7.56E-20 0.6822 7.63E-18 2.11E-23
0.7803
2.03E-21
5.79E-11 0.4464 4.05E-09 8.22E-11
0.4748
5.34E-09
3.90E-06 0.2546 0.000109 3.10E-06
0.2825
7.13E-05
1.34E-25 0.7785 1.39E-23 2.02E-25
0.8090
1.98E-23
2.39E-17 0.6283 2.24E-15 1.44E-17
0.6706
1.26E-15
4.00E-10 0.4169 2.52E-08 3.73E-10
0.4506
2.24E-08
6.06E-08 0.3328 2.87E-06 1.34E-07
0.3458
4.84E-06
1.57E-08 0.3564 8.65E-07 1.96E-07
0.3385
6.66E-06
1.38E-17 0.6338 1.32E-15 2.85E-16
0.6397
2.42E-14
2.54E-10 0.4240 1.70E-08 2.42E-10
0.4577
1.47E-08
3.19E-05 0.2122 0.000671 6.80E-06
0.2659
0.000143
0.003198 0.1130 0.044776 0.006829
0.1057
0.061463
0.181249 0.0244
1
0.221529
0.0226
0.886115
2.83E-06 0.2610 8.49E-05 1.95E-06
0.2923
5.06E-05
1.41E-06 0.2745 4.94E-05 7.50E-07
0.3118
2.17E-05
8.18E-07 0.2849 3.11E-05 8.81E-08
0.3539
3.35E-06
1.74E-05 0.2247 0.0004
0.0002
0.1903
0.002997
7.74E-07 0.2859 3.02E-05 1.69E-08
0.3847
8.31E-07
2.36E-19 0.6722 2.36E-17 3.98E-19
0.7043
3.67E-17
5.45E-10 0.4120 3.38E-08 2.38E-08
0.3785
1.14E-06
2.28E-12 0.4927 1.73E-10 2.28E-13
0.5596
1.76E-11
3.24E-06 0.2583 9.39E-05 4.35E-05
0.2251
0.000783
1.71E-06 0.2707 5.82E-05 1.67E-06
0.2955
4.50E-05
0.018239 0.0740 0.200627 [removed] [removed] [removed]
0.001833 0.1253 0.029323 [removed] [removed] [removed]
0.007779 0.0931 0.101128 0.004254
0.1173
0.046794
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Finegoldia magna
Fusobacterium cluster48
Gardnerella vaginalis
Gardnerella vaginalis BT
Gemella OTU86
Helcococcus ovis BT
Lachnospiraceae BVAB1
Lachnospiraceae BVAB1 BT
Lachnospiraceae OTU33
Lactobacillus coleohominis
Lactobacillus coleohominis BT
Lactobacillus crispatus_cluster
Lactobacillus crispatus_cluster BT
Lactobacillus gasseri_cluster
Lactobacillus gasseri_cluster BT
Lactobacillus iners
Lactobacillus iners BT
Lactobacillus jensenii
Lactobacillus jensenii BT
Lactobacillus vaginalis
Megasphaera cluster52
Megasphaera cluster52 BT
Microbacterium cluster35 BT
Mobiluncus curtisii
Mobiluncus mulieris
Moryella indoligenes BT
Mycoplasma hominis
Mycoplasma hominis BT
Neisseria gonorrhoeae BT
No Hit BT
Parvimonas OTU142
Parvimonas OTU142 BT
Peptoniphilus harei
Peptoniphilus indolicus
Peptoniphilus indolicus BT
Peptoniphilus ivorii BT
Peptoniphilus lacrimalis
Peptoniphilus lacrimalis BT
Peptoniphilus OTU42
Peptoniphilus OTU42 BT
Peptostreptococcus anaerobius
Porphyromonadaceae OTU134
Porphyromonadaceae OTU134 BT
Porphyromonas bennonis

0.001132
2.07E-06
3.91E-25
7.76E-14
1.10E-11
3.58E-10
1.76E-17
3.27E-12
6.52E-07
7.68E-26
1.17E-08
3.88E-08
0.002342
3.94E-13
0.000558
5.47E-19
0.000352
1.35E-27
1.28E-11
1.04E-29
9.61E-22
3.58E-09
0.517337
1.37E-06
4.69E-11
7.00E-14
4.49E-15
2.08E-05
0.370999
0.055291
5.41E-27
1.65E-14
1.02E-06
2.20E-06
2.37E-07
6.83E-08
4.67E-08
1.95E-08
2.92E-10
6.73E-11
1.23E-05
7.48E-13
5.49E-11
1.95E-08

0.1360
0.2670
0.7719
0.5371
0.4706
0.4186
0.6314
0.4878
0.2892
0.7818
0.3615
0.3407
0.1199
0.5162
0.1515
0.6646
0.1615
0.8046
0.4685
0.8289
0.7178
0.3815
0.0058
0.2750
0.4496
0.5384
0.5715
0.2211
0.0110
0.0494
0.7971
0.5561
0.2807
0.2658
0.3080
0.3307
0.3374
0.3527
0.4218
0.4442
0.2318
0.5078
0.4472
0.3527

0.019437
6.63E-05
4.03E-23
6.44E-12
8.17E-10
2.29E-08
1.68E-15
2.45E-10
2.61E-05
8.06E-24
6.57E-07
1.98E-06
0.035136
3.20E-11
0.010607
5.41E-17
0.007032
1.49E-25
9.34E-10
1.16E-27
9.81E-20
2.08E-07
1
4.94E-05
3.37E-09
5.88E-12
3.95E-13
0.000457
1
0.497618
5.73E-25
1.40E-12
3.76E-05
6.83E-05
9.72E-06
3.14E-06
2.34E-06
1.05E-06
1.91E-08
4.65E-09
0.000295
5.91E-11
3.90E-09
1.05E-06

0.000515
1.66E-08
2.39E-30
3.60E-13
1.21E-11
9.08E-10
8.72E-17
1.50E-13
2.81E-06
1.61E-23
6.96E-08
2.92E-08
0.003673
4.07E-13
0.014782
6.15E-30
0.004787
4.42E-29
8.22E-11
5.97E-34
4.59E-22
2.99E-09
0.408734
1.49E-08
1.07E-10
8.60E-15
2.43E-13
7.48E-05
0.590943
0.031604
1.89E-25
5.69E-13
7.84E-07
6.56E-07
3.37E-07
2.03E-07
3.39E-08
4.39E-08
4.27E-09
4.69E-10
3.13E-05
2.38E-12
7.78E-10
2.18E-06

0.1681
0.3850
0.8645
0.5535
0.5041
0.4359
0.6523
0.5651
0.2846
0.7820
0.3584
0.3747
0.1209
0.5519
0.0867
0.8605
0.1144
0.8520
0.4748
0.8945
0.7589
0.4155
0.0104
0.3871
0.4708
0.6009
0.5588
0.2129
0.0044
0.0681
0.8094
0.5474
0.3109
0.3145
0.3278
0.3378
0.3719
0.3671
0.4093
0.4469
0.2325
0.5276
0.4385
0.2899

0.007212
8.31E-07
2.46E-28
2.70E-11
8.09E-10
5.18E-08
7.50E-15
1.19E-11
6.75E-05
1.57E-21
2.78E-06
1.34E-06
0.044078
3.01E-11
0.103473
6.27E-28
0.047865
4.46E-27
5.34E-09
6.27E-32
4.32E-20
1.65E-07
1
7.73E-07
6.72E-09
7.13E-13
1.84E-11
0.001272
1
0.158018
1.87E-23
4.16E-11
2.20E-05
1.97E-05
1.08E-05
6.68E-06
1.53E-06
1.93E-06
2.30E-07
2.77E-08
0.000601
1.69E-10
4.51E-08
5.44E-05
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Porphyromonas uenonis_asaccharolytica
Prevotella amnii
Prevotella amnii BT
Prevotella bivia
Prevotella cluster2
Prevotella cluster2 BT
Prevotella corporis
Prevotella disiens
Prevotella OTU44
Prevotella OTU48
Prevotella OTU49
Prevotellaceae OTU61
Propionibacterium acnes
Sneathia amnii
Sneathia amnii BT
Sneathia sanguinegens
Sneathia sanguinegens BT
Staphylococcus cluster47
Staphylococcus cluster47 BT
Streptococcus anginosus
Streptococcus cluster29
Streptococcus cluster29 BT
S.salivarius_thermophilus_vestibularis
S. salivarius_thermophilus_vestibularis BT
TM7 OTU-H1
TM7 OTU-H1 BT
Ureaplasma cluster23
Ureaplasma cluster23 BT

5.22E-08
1.94E-16
8.36E-15
0.00108
9.18E-13
3.59E-08
3.44E-09
1.74E-06
2.39E-15
3.37E-09
2.49E-27
3.79E-27
0.413503
9.89E-18
5.31E-13
1.21E-14
2.09E-12
7.30E-06
0.014862
7.91E-08
0.238449
0.400789
0.428634
0.256345
1.20E-16
5.99E-08
2.90E-10
0.023851

0.3354
0.6065
0.5642
0.1370
0.5051
0.3421
0.3821
0.2704
0.5788
0.3825
0.8013
0.7991
0.0092
0.6371
0.5123
0.5598
0.4940
0.2422
0.0786
0.3280
0.0190
0.0097
0.0086
0.0176
0.6117
0.3330
0.4219
0.0680

2.56E-06
1.74E-14
7.28E-13
0.019437
7.16E-11
1.87E-06
2.03E-07
5.82E-05
2.12E-13
2.02E-07
2.72E-25
4.05E-25
1
9.59E-16
4.25E-11
1.04E-12
1.61E-10
0.000183
0.17834
3.56E-06
1
1
1
1
1.09E-14
2.87E-06
1.91E-08
0.238509

5.07E-08
1.43E-15
5.84E-14
0.001054
2.06E-13
1.15E-07
5.45E-09
3.45E-06
1.75E-14
1.53E-08
4.63E-32
8.52E-26
[removed]
1.57E-19
1.08E-11
1.54E-14
4.94E-12
4.57E-07
0.006938
6.20E-08
0.571378
[removed]
[removed]
[removed]
1.37E-17
3.04E-11
7.34E-12
0.018542

0.3644
0.6218
0.5772
0.1511
0.5610
0.3488
0.4050
0.2803
0.5922
0.3866
0.8797
0.8140
[removed]
0.7125
0.5057
0.5938
0.5172
0.3218
0.1053
0.3606
0.0049
[removed]
[removed]
[removed]
0.6711
0.4902
0.5114
0.0812

2.18E-06
1.20E-13
4.67E-12
0.013698
1.61E-11
4.26E-06
2.89E-07
7.60E-05
1.42E-12
7.78E-07
4.81E-30
8.52E-24
[removed]
1.46E-17
7.34E-10
1.26E-12
3.46E-10
1.42E-05
0.061463
2.54E-06
1
[removed]
[removed]
[removed]
1.21E-15
2.01E-09
5.06E-10
0.111252

Table 1: Linear relationship of relative abundance of all taxa found in both body sites
based on paired samples. Data is shown as original abundance correlation and abundance
correlation after the removal of Propionibacterium acnes, Streptococcus
salivarius_thermophilus_vestibularis, Enterobacteriaceae cluster31, Streptococcus
salivarius_thermophilus_vestibularis BT, Enterobacteriaceae cluster31 BT, and Streptococcus
cluster29 BT. The p-value of the linear regression is corrected using the Benjamini–Hochberg
procedure with a false discovery rate (FDR) of 5%.
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